Completed
Serologic Response to SHINGRIX Vaccine in Patients With CLL and WM Treated With BTK Inhibitors
NCT03771157
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +23 more
- Locations
-
- University of Rochester Rochester, New York, United States